Innovations for Changing the Face of Women’s Reproductive Health Therapeutics

At ObsEva, our passion and expertise in reproductive health and pregnancy therapeutics is helping millions of women worldwide lead healthier and more fulfilling lives.

Significant Unmet Needs in Reproductive Health

Millions of women worldwide suffer from reproductive health conditions that affect their quality of life or ability to conceive and may lead to complications during pregnancy.

Innovation From Conception to Birth and Beyond

ObsEva is advancing a robust pipeline of novel, orally-administered, clinical-stage compounds in the areas of uterine fibroids, endometriosis, assisted reproductive technology, and preterm labor.

Recent Updates

07 Dec 2017

ObsEva SA to Participate in BMO Healthcare Conference December 14th 2017

Read more
05 Dec 2017

ObsEva Initiates PROLONG, the Phase 2a Clinical Trial of OBE022 in Preterm Labor

Read more
14 Nov 2017

ObsEva Reports Third Quarter 2017 Financial Results and Provides Business Update

Read more
07 Nov 2017

ObsEva SA Announces the Completion of Patient Recruitment in the EDELWEISS Phase 2b Clinical Trial of OBE2109 for the Treatment of Endometriosis

Read more